{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:11:44Z","timestamp":1786119104424,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1097\/mph.0b013e31818b3584","type":"journal-article","created":{"date-parts":[[2009,1,8]],"date-time":"2009-01-08T03:13:47Z","timestamp":1231384427000},"page":"972-975","source":"Crossref","is-referenced-by-count":1,"title":["Successful Salvage Chemotherapy for Isolated Central Nervous System (CNS) Relapse in Burkitt Lymphoma"],"prefix":"10.1097","volume":"30","author":[{"given":"Frederic","family":"Baleydier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Pondarre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Pierre","family":"Pages","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Mialou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila","family":"Kebaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Pracros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-27-20210227","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/pbc.20342","article-title":"Childhood and adolescent non-Hodgkin lymphoma: new insights in biology and critical challenges for the future","volume":"45","author":"Cairo","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"R2-27-20210227","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1182\/blood.V97.11.3370","article-title":"The Societe Francaise d'Oncologie Pediatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia","volume":"97","author":"Patte","year":"2001","journal-title":"Blood"},{"key":"R3-27-20210227","first-page":"3294","article-title":"Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90","volume":"94","author":"Reiter","year":"1999","journal-title":"Blood"},{"key":"R4-27-20210227","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2006-07-036673","article-title":"Results of the randomized international FAB\/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients","volume":"109","author":"Patte","year":"2007","journal-title":"Blood"},{"key":"R5-27-20210227","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1182\/blood-2006-07-036665","article-title":"Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents","volume":"109","author":"Cairo","year":"2007","journal-title":"Blood"},{"key":"R6-27-20210227","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1046\/j.1365-2141.2001.02647.x","article-title":"Outcome of relapsed or refractory childhood B-cell acute lymphoblastic leukaemia and B-cell non-Hodgkin's lymphoma treated with the UKCCSG 9003\/9002 protocols","volume":"112","author":"Atra","year":"2001","journal-title":"Br J Haematol"},{"key":"R7-27-20210227","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1046\/j.1365-2141.2003.04134.x","article-title":"Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of the Children's Cancer Group experience","volume":"120","author":"Cairo","year":"2003","journal-title":"Br J Haematol"},{"key":"R8-27-20210227","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1200\/JCO.1986.4.8.1219","article-title":"Improved survival rate in children with stage III and IV B cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: results of a study of 114 children from the French Pediatric Oncology Society","volume":"4","author":"Patte","year":"1986","journal-title":"J Clin Oncol"},{"key":"R9-27-20210227","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1200\/JCO.1991.9.1.123","article-title":"High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children","volume":"9","author":"Patte","year":"1991","journal-title":"J Clin Oncol"},{"key":"R10-27-20210227","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1182\/blood.V90.8.2921","article-title":"High-dose chemotherapy with autologous bone marrow rescue in children with poor-risk Burkitt's lymphoma: a report from the European Lymphoma Bone Marrow Transplantation Registry","volume":"90","author":"Ladenstein","year":"1997","journal-title":"Blood"},{"key":"R11-27-20210227","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood.V81.8.2003.2003","article-title":"Curability of relapsed childhood B-cell non-Hodgkin's lymphoma after intensive first line therapy: a report from the Societe Francaise d'Oncologie Pediatrique","volume":"81","author":"Philip","year":"1993","journal-title":"Blood"},{"key":"R12-27-20210227","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00043426-200205000-00011","article-title":"Intrathecal thiotepa: reappraisal of an established therapy","volume":"24","author":"Fisher","year":"2002","journal-title":"J Pediatr Hematol Oncol"},{"key":"R13-27-20210227","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/1097-0142(197610)38:4<1471::AID-CNCR2820380404>3.0.CO;2-0","article-title":"Intrathecal N, N\u2032, N\u2033-triethylenethiophosphoramide [thio-TEPA (NSC 6396)] in the treatment of malignant meningeal disease: phase I-II study","volume":"38","author":"Gutin","year":"1976","journal-title":"Cancer"},{"key":"R14-27-20210227","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1200\/JCO.2005.03.3373","article-title":"Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a Pediatric Oncology Group Study","volume":"24","author":"Barredo","year":"2006","journal-title":"J Clin Oncol"},{"key":"R15-27-20210227","first-page":"736","article-title":"Phase I and pharmacokinetic evaluation of thiotepa in the cerebrospinal fluid and plasma of pediatric patients: evidence for dose-dependent plasma clearance of thiotepa","volume":"49","author":"Heideman","year":"1989","journal-title":"Cancer Res"},{"key":"R16-27-20210227","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood-2004-03-0973","article-title":"The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95","volume":"105","author":"Woessmann","year":"2005","journal-title":"Blood"},{"key":"R17-27-20210227","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1182\/blood-2002-06-1636","article-title":"Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment","volume":"101","author":"Rubenstein","year":"2003","journal-title":"Blood"},{"key":"R18-27-20210227","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1200\/JCO.2006.09.7311","article-title":"Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma","volume":"25","author":"Rubenstein","year":"2007","journal-title":"J Clin Oncol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0b013e31818b3584","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:30:54Z","timestamp":1786037454000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00043426-200812000-00027"}},"subtitle":["Monocentric Experience of 3 Pediatric Patients"],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e31818b3584","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}